dexmedetomidine has been researched along with Parkinson Disease in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 8 (57.14) | 24.3611 |
| 2020's | 4 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, M; Ma, T; Xie, H; Xie, Q; Zhang, Q; Zhou, L | 1 |
| Chen, Y; Cheng, O; Cui, J; Li, C; Li, Y; Zhu, D | 1 |
| Jin, H; Li, S; Liu, X; Ma, T; Peng, Y; Shen, Z; Wang, J; Yao, J; Zeng, M | 1 |
| Aldaz, A; Alegre, M; Cacho-Asenjo, E; Guridi, J; Honorato-Cia, C; Manzanilla, O; Martinez-Simon, A; Nuñez-Cordoba, JM; Panadero, A; Valencia, M | 1 |
| Alegre, M; Cacho-Asenjo, E; Carmona-Abellán, M; Guridi, J; Honorato-Cia, C; Martinez-Simon, A; Nuñez-Cordoba, JM; Trocóniz, IF; Valencia, M | 1 |
| Colantonio, LB; De Sanctis, F; Di Carlo, S; Fusco, P; Marinangeli, F; Masciocchi, C; Petrucci, E; Scimia, P | 1 |
| Lan, F; Li, JS; Tian, ZL; Wang, TL | 1 |
| Basha, D; Elias, G; Fasano, A; Hodaie, M; Hutchison, WD; Kalia, SK; King, NK; Krishna, V; Lozano, AM; Munhoz, R; Sammartino, F; Venkatraghavan, L | 1 |
| Alegre, M; Cacho-Asenjo, E; Guridi, J; Honorato-Cia, C; Martínez-Simón, A; Núñez-Córdoba, JM; Panadero, A | 1 |
| Aglialoro, E; Aloj, F; Cavallo, L; De Angelis, M; Esposito, V; Maucione, G; Modugno, N; Morace, R; Santilli, M; Solari, D | 1 |
| Kim, JH; Koh, SB; Kwon, TH; Kwon, WK; Lee, IO; Lee, JH; Lim, BG | 1 |
| Camalier, CR; Kla, KM; Konrad, PE; Mathews, L; Mitchell, MD; Neimat, JS; Smithson, KG | 1 |
| Deogaonkar, A; Deogaonkar, M; Ebrahim, Z; Lee, JY; Schubert, A | 1 |
| Domino, KJ; Goodkin, R; Lam, AM; Lee, LA; Muangman, S; Rozet, I; Slimp, JC; Souter, MJ; Vavilala, MS | 1 |
1 review(s) available for dexmedetomidine and Parkinson Disease
| Article | Year |
|---|---|
Sedation with α2 Agonist Dexmedetomidine During Unilateral Subthalamic Nucleus Deep Brain Stimulation: A Preliminary Report.
Topics: Adrenergic alpha-2 Receptor Agonists; Aged; Antiparkinson Agents; Deep Brain Stimulation; Dexmedetomidine; Female; Follow-Up Studies; Humans; Hypnotics and Sedatives; Intraoperative Neurophysiological Monitoring; Male; Middle Aged; Motor Activity; Neuropsychological Tests; Parkinson Disease; Reaction Time; Retrospective Studies; Severity of Illness Index; Speech; Subthalamic Nucleus; Treatment Outcome | 2016 |
2 trial(s) available for dexmedetomidine and Parkinson Disease
| Article | Year |
|---|---|
Dexmedetomidine after deep brain stimulation for prevention of delirium in elderly patients with Parkinson's disease: protocol for a single-centre, randomised, double-blind, placebo-controlled trial in China.
Topics: Aged; China; Confusion; Deep Brain Stimulation; Dexmedetomidine; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Emergence Delirium; Humans; Parkinson Disease; Quality of Life; Randomized Controlled Trials as Topic | 2023 |
[Application of dexmedetomidine for brain nuclei lesion of patients with Parkinson's disease].
Topics: Aged; Brain; Dexmedetomidine; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Monitoring, Intraoperative; Parkinson Disease; Prospective Studies | 2013 |
11 other study(ies) available for dexmedetomidine and Parkinson Disease
| Article | Year |
|---|---|
Dexmedetomidine attenuates motor deficits via restoring the function of neurons in the nigrostriatal circuit in Parkinson's disease model mice.
Topics: Animals; Corpus Striatum; Dexmedetomidine; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Humans; Mice; Mice, Inbred C57BL; Parkinson Disease | 2022 |
Dexmedetomidine alleviates pain in MPTP-treated mice by activating the AMPK/mTOR/NF-κB pathways in astrocytes.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; AMP-Activated Protein Kinases; Animals; Astrocytes; Dexmedetomidine; Disease Models, Animal; Dopaminergic Neurons; Interleukin-6; Mice; Mice, Inbred C57BL; NF-kappa B; Pain; Parkinson Disease; Quality of Life; TOR Serine-Threonine Kinases; Tumor Necrosis Factor-alpha | 2022 |
Effects of dexmedetomidine on subthalamic local field potentials in Parkinson's disease.
Topics: Deep Brain Stimulation; Dexmedetomidine; Dose-Response Relationship, Drug; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Parkinson Disease; Spain; Subthalamic Nucleus | 2021 |
Effect of Dexmedetomidine and Propofol on Basal Ganglia Activity in Parkinson Disease: A Controlled Clinical Trial.
Topics: Action Potentials; Aged; Basal Ganglia; Deep Brain Stimulation; Dexmedetomidine; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Parkinson Disease; Propofol | 2017 |
Dexmedetomidine Sedation in Magnetic Resonance-Guided Focused Ultrasound Thalamotomy: A Case Series of 3 Patients.
Topics: Aged; Dexmedetomidine; Essential Tremor; Female; Humans; Hypnotics and Sedatives; Magnetic Resonance Imaging; Male; Middle Aged; Movement Disorders; Parkinson Disease; Psychosurgery; Thalamus; Treatment Outcome; Ultrasonography | 2019 |
The effect of dexmedetomidine on the firing properties of STN neurons in Parkinson's disease.
Topics: Action Potentials; Analgesics, Non-Narcotic; Deep Brain Stimulation; Dexmedetomidine; Dose-Response Relationship, Drug; Female; Humans; Male; Microelectrodes; Middle Aged; Neurons; Parkinson Disease; Statistics, Nonparametric; Subthalamic Nucleus | 2015 |
Factors Associated with Tremor Changes during Sedation with Dexmedetomidine in Parkinson's Disease Surgery.
Topics: Adult; Aged; Deep Brain Stimulation; Dexmedetomidine; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Parkinson Disease; Retrospective Studies; Treatment Outcome; Tremor | 2015 |
Microelectrode recording (MER) findings during sleep-awake anesthesia using dexmedetomidine in deep brain stimulation surgery for Parkinson's disease.
Topics: Aged; Anesthesia, Local; Deep Brain Stimulation; Dexmedetomidine; Female; Humans; Hypnotics and Sedatives; Male; Microelectrodes; Middle Aged; Parkinson Disease; Retrospective Studies; Sleep; Wakefulness | 2016 |
The Effects of Dexmedetomidine on Microelectrode Recordings of the Subthalamic Nucleus during Deep Brain Stimulation Surgery: A Retrospective Analysis.
Topics: Action Potentials; Aged; Deep Brain Stimulation; Dexmedetomidine; Female; Humans; Male; Microelectrodes; Middle Aged; Neurons; Parkinson Disease; Piperidines; Remifentanil; Retrospective Studies; Subthalamic Nucleus | 2017 |
Propofol-induced dyskinesias controlled with dexmedetomidine during deep brain stimulation surgery.
Topics: Deep Brain Stimulation; Dexmedetomidine; Dyskinesia, Drug-Induced; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Parkinson Disease; Propofol | 2006 |
Clinical experience with dexmedetomidine for implantation of deep brain stimulators in Parkinson's disease.
Topics: Aged; Blood Pressure; Deep Brain Stimulation; Dexmedetomidine; Dose-Response Relationship, Drug; Electrodes, Implanted; Female; Humans; Male; Middle Aged; Parkinson Disease; Retrospective Studies | 2006 |